AND017
In normoxia, the enzyme called prolyl hydroxylase (PH) can hydroxylate hypoxiainducible-factor (HIF)
MORE
Program | Indication | Discovery | IND Approval | Phase I | Phase II | |
AND017 (HIF-PHI) |
Anemia |
![]() Phase II FDA IND Approval on Jan 14 2021 |
||||
AND017 (HIF-PHI) |
Cancer Related Anemia |
![]() Phase II NMPA Approval on May 23 2022 |
||||
AND019(SERD) |
Breast Cancer |
![]() Phase I FDA IND Approval on Oct 1 2021 |
||||
ADC |
Cancers |
![]() Pre-Clinical |
||||
AND021 |
Renal Cell Carcinoma |
![]() Pre- Clinical |